| Literature DB >> 34497642 |
Pham Hoang Ha1,2, Nguyen Xuan Hoa1.
Abstract
OBJECTIVE: There have been surgical procedures to reconstruct the gastrointestinal continuity after distal gastrectomy. This study is aimed at comparing the surgical outcomes of reconstructing gastrointestinal continuity by the method of Finsterer and Roux-en-Y after distal gastrectomy due to cancer. Materials and methods. 86 patients, who underwent distal gastrectomy due to cancer, were divided into 2 groups for reconstructing gastrointestinal continuity from March 2014 to August 2018 at Viet Duc Hospital: group 1 (44 patients) by the Finsterer method and group 2 (42 patients) by the Roux-en-Y method.Entities:
Year: 2021 PMID: 34497642 PMCID: PMC8419505 DOI: 10.1155/2021/5562776
Source DB: PubMed Journal: Gastroenterol Res Pract ISSN: 1687-6121 Impact factor: 2.260
Gastric anastomosis status evaluated by endoscopy.
| Group | ||||||
|---|---|---|---|---|---|---|
| Indicator | Finsterer ( | Roux-en-Y ( |
| |||
|
| % |
| % | |||
| Anastomotic inflammation | Yes | 25 | 71.4 | 14 | 43.8 | 0.027 |
| No | 10 | 28.6 | 18 | 56,2 | ||
| Bile reflux | Yes | 21 | 60 | 1 | 3.1 | <0.01 |
| No | 14 | 40 | 31 | 96.9 | ||
Concentration of bilirubin and amylase in gastric juice.
| Group | ||||
|---|---|---|---|---|
| C (mmol) | Finsterer ( | Roux-en-Y ( |
| |
| The first day after surgery | Bilirubin | 26.25 (0.3-763) | 2.14 (0-1270) | <0.01 |
| Amylase | 23510 (0-377200) | 1358 (1-126754) | <0.01 | |
| The day after the first flatus | Bilirubin | 97.6 (0.3-936) | 0.5 (0–548.3) | <0.01 |
| Amylase | 20016 (0-152300) | 152 (0-14310) | <0.01 | |
Dumping syndrome.
| Group | ||||||
|---|---|---|---|---|---|---|
| Syndrome | Finsterer ( | Roux-en-Y ( |
| |||
|
| % |
| % | |||
| Early dumping | Yes | 7 | 20 | 3 | 9.4 | 0.310 |
| No | 28 | 80 | 29 | 90.6 | ||
| Late dumping | Yes | 0 | 0 | 0 | 0 | |
| No | 35 | 100 | 32 | 100 | ||
Body weight change.
| Group | |||
|---|---|---|---|
| Body weight (kg) (mean ± SD) | Finsterer ( | Roux-en-Y ( |
|
| Before surgery | 55.09 ± 6.87 | 53.10 ± 7.84 | 0.394 |
| After surgery | 54.34 ± 7.72 | 52.82 ± 7.07 | |
| Change in body weight | 0.75 ± 3.92 | 0.28 ± 3.47 | |
Clinicopathologic characteristics of the two groups of patients.
| Finsterer ( | Roux en Y ( |
| |
|---|---|---|---|
| Age (years) | 55.2 ± 9.6 (35-72) | 57.6 ± 11.6 (27-77) | >0.05 |
| Male sex (%) | 70.45 | 61.90 | >0.05 |
| BMI < 18 (%) | 11.36 | 16.28 | 0.035 |
| Time of operation (minutes) | 155.7 ± 25.9 (90–200) | 170.3 ± 22.3 (120–215) | 0.007 |
| Number of dissected lymphnode | 19.1 ± 4.8 (13–37) | 20.3 ± 4.5 (12–33) | 0.243 |
| Number of positive lymphnode | 1.8 ± 2.5 (0–18) | 2.6 ± 3.9 (0–10) | 0.253 |
| Tumor stage | 0.631 | ||
| T1a | 2 | 2 | |
| T1b | 2 | 3 | |
| T2 | 13 | 10 | |
| T3 | 15 | 20 | |
| T4a | 12 | 7 | |
| T4b | 0 | 0 | |
| Node stage | 0.199 | ||
| N0 | 22 | 20 | |
| N1 | 9 | 8 | |
| N2 | 12 | 7 | |
| N3a | 1 | 6 | |
| N3b | 0 | 1 | |
| TNM stage | 0.253 | ||
| Ia | 4 | 5 | |
| Ib | 12 | 4 | |
| IIa | 7 | 12 | |
| IIb | 5 | 4 | |
| IIIa | 7 | 10 | |
| IIIb | 9 | 6 | |
| IIIc | 0 | 1 | |
| Tumor grade | 0.22 | ||
| Well-differentiated | 6 | 4 | |
| Moderately differentiated | 19 | 26 | |
| Poorly differentiated | 19 | 12 |
Early outcomes after surgery.
| Early results | Finsterer ( | Roux-en-Y ( |
|
|---|---|---|---|
| Time to first flatus (days) | 3.6 ± 0.6 | 4.0 ± 0.6 | 0.5 |
| Time for stomach catheterization (days) | 4.9 ± 0.7 | 4.8 ± 0.8 | 0.391 |
| Time to oral feeding (days) | 5.7 ± 0.8 | 5.3 ± 1.0 | 0.054 |
| Wound dehiscence (%) | 1 (2.3%) | 0 | |
| Wound infection (%) | 2 (4.5%) | 5 (11.9%) | 0.26 |
| Postoperative intra-abdominal abscess | 0 | 1 (2.4) |